XML 24 R8.htm IDEA: XBRL DOCUMENT v3.10.0.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2016
Operating activities      
Net income $ 447,098 $ 487,848 $ 396,831
Adjustments to reconcile net income to net cash provided by operating activities:      
Intangible asset amortization 201,498 152,065 101,994
Share-based compensation 102,441 106,900 98,771
Impairment charges 42,896 0 0
Depreciation 15,233 13,089 11,786
Acquired in-process research and development 0 85,000 23,750
Loss on disposal of assets 655 473 47
Deferred tax benefit (88,815) (225,591) (41,163)
Provision for losses on accounts receivable and inventory 4,728 2,190 2,209
Loss on extinguishment and modification of debt 1,425 0 638
Amortization of debt discount and deferred financing costs 43,960 30,026 22,133
Other non-cash transactions 4,499 14,321 (3,741)
Changes in assets and liabilities:      
Accounts receivable (40,132) 12,278 (25,603)
Inventories (18,512) (8,667) (17,024)
Prepaid expenses and other current assets 6,697 (26,874) (15,700)
Other non-current assets (320) 119 267
Accounts payable 17,040 214 361
Accrued liabilities 71,208 (6,578) 11,989
Income taxes payable (19,735) 16,331 2,962
Deferred revenue (7,497) 21,009 (1,315)
Other non-current liabilities 14,537 18,934 23,199
Net cash provided by operating activities 798,904 693,087 592,391
Investing activities      
Acquisition of investments (1,165,915) (385,000) (132,181)
Proceeds from maturity of investments 855,000 230,000 66,906
Acquired in-process research and development 0 (85,000) (23,750)
Purchases of property, plant and equipment (20,370) (28,950) (9,687)
Acquisitions, net of cash acquired 0 0 (1,502,443)
Acquisition of intangible assets (111,100) 0 (150,000)
Net proceeds from sale of assets 47,898 0 0
Net cash used in investing activities (394,487) (268,950) (1,751,155)
Financing activities      
Net proceeds from issuance of debt 0 559,393 994,647
Proceeds from employee equity incentive and purchase plans 93,337 31,824 24,174
Share repurchases (523,672) (98,799) (278,296)
Payment of employee withholding taxes related to share-based awards (17,925) (18,589) (21,234)
Repayments of long-term debt (25,717) (36,094) (28,304)
Payment of debt modification costs (6,406) 0 0
Repayments under revolving credit facility 0 (850,000) (150,000)
Proceeds from tenant improvement allowance on build-to-suit lease 1,253 3,154 0
Net cash provided by (used in) financing activities (479,130) (409,111) 540,987
Effect of exchange rates on cash and cash equivalents (1,700) 5,046 (5,045)
Net increase (decrease) in cash and cash equivalents (76,413) 20,072 (622,822)
Cash and cash equivalents, at beginning of period 386,035 365,963 988,785
Cash and cash equivalents, at end of period 309,622 386,035 365,963
Supplemental disclosure of cash flow information:      
Cash paid for interest 42,706 44,609 39,898
Cash paid for income taxes 164,217 174,124 160,306
Non-cash investing activities:      
Amounts capitalized in connection with facility lease obligations $ 27,747 $ 40,970 $ 23,799